Maha Katabi, Director at RayzeBio, Inc. (RYZB), bought 1,209,764 shares at $18.00 ($4.2M) on 2023-09-19, disclosed to the SEC on 2023-09-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 973,653 | $0 | 0.0% |
| 2 | $18.00 | 236,111 | $4.2M | 100.0% |
| Total | $3.51 avg | 1,209,764 | $4.2M | 100% |
| Filing → |
| VERA | BUY | 2022-02-14 | $4.0M | — | Filing → |
| AVTE | BUY | 2021-07-06 | $5.0M | — | Filing → |
| VERA | BUY | 2021-05-18 | $8.0M | — | Filing → |